Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

New Guidance for Early-Stage Lung Cancer Patients

October 16, 2014 8:50 am | Videos | Comments

Researchers in Texas say that removing the entire lung instead of part increases the chance of survival for early-stage lung cancer patients. Also, there more research linking psoriasis and high blood pressure.        

TOPICS:

FDA Approves Esbriet to Treat Idiopathic Pulmonary Fibrosis

October 16, 2014 8:41 am | News | Comments

Idiopathic pulmonary fibrosis is a condition in which the lungs become progressively scarred over time. As a result, patients with IPF experience shortness of breath, cough, and have difficulty participating in everyday physical activities.  

TOPICS:

Existing Protocols Might Not Be Enough for Ebola

October 16, 2014 8:31 am | by MARTHA MENDOZA, AP National Writer | News | Comments

As Thomas Eric Duncan's health deteriorated, nurses Amber Joy Vinson and Nina Pham were at the Ebola patient's side. They wore protective gear including face shields, hazardous materials suits and protective footwear as they inserted catheters, drew blood and dealt with his body fluids. Still, the two somehow contracted Ebola from the dying man.

TOPICS:
Advertisement

US Steps Up Domestic Response to Ebola Crisis

October 16, 2014 8:24 am | by JIM KUHNHENN, Associated Press | News | Comments

The federal government is ramping up its response to the Ebola crisis after a second Dallas nurse became ill and it was disclosed that she had been cleared to fly a day before her diagnosis.          

TOPICS:

Roche Posts Flat Nine-Month Sales

October 16, 2014 8:14 am | by JOHN HEILPRIN, Associated Press | News | Comments

Roche Holding AG posted flat sales for the first nine months of 2014, but said Thursday the results show strong demand for its cancer drugs and emerging new products.              

TOPICS:

AbbVie Wants Out of $55B Shire Deal

October 16, 2014 8:11 am | by The Associated Press | News | Comments

AbbVie's board is telling shareholders to vote against its own $55 billion takeover bid for the Irish drugmaker Shire after the U.S. made reincorporating overseas a less lucrative tax maneuver.          

TOPICS:

A Roadmap for Risky Territory

October 15, 2014 3:49 pm | by Jamie T. Hintlian and Ryan Kelly; Ernst & Young | Articles | Comments

When it comes to the supply chain, business can be risky. A seminal survey of companies in various industries spanning 62 countries found 85% of respondents have experienced a supply chain disruption over the last 12 months, and 50% of companies had more than one disruption.

TOPICS:

Mylan Recalls Some Lots of Nitroglycerin Spray Used to Treat Angina

October 15, 2014 2:14 pm | by The Canadian Press | News | Comments

Some lots of the product, called Mylan-Nitro Sublingual Spray 0.4 mg Per Metered Dose, are potentially missing the dip tube, a part of the pump component. A missing dip tube could pose a problem with delivery of nitroglycerin to the patient.  

TOPICS:
Advertisement

The Perils of Supply Chain EHS Performance Neglect, and 5 Solutions

October 15, 2014 2:10 pm | by Paul Leavoy, Research Analyst, LNS Research | Blogs | Comments

The need to manage environment, health and safety (EHS) performance across our organizations and throughout our global plants has never been more apparent. While considerations of EHS performance were once limited to one organization’s performance within its four walls, things have changed.

TOPICS:

Supreme Court Weighs Generic Drug Dispute

October 15, 2014 1:28 pm | by SAM HANANEL, Associated Press | News | Comments

The Supreme Court seems divided as it considers a high-stakes patent dispute between rival pharmaceutical companies over the world's best-selling multiple sclerosis treatment.             

TOPICS:

Chemical-Resistant Film

October 15, 2014 11:11 am | by Nikita Ernst, Associate Editor | Product Releases | Comments

The new Exponent film represents a collaboration between Ineos’ Barex and Rollprint’s own ClearFoil and targets pharmaceutical and other chemically-sensitive applications which require exceptional barrier and clarity. 

Vetter Announces Personnel Changes in its Development Service Division

October 15, 2014 10:31 am | News | Comments

Vetter, a contract development and manufacturing organization (CDMO), today officially announced a series of adjustments to its Development Service related structures designed to support its customer base.        

TOPICS:

West Pharmaceutical Services Announces CEO Retirement and Succession Plan

October 15, 2014 8:59 am | News | Comments

West Pharmaceutical Services said today that Donald E. Morel, Jr., Ph.D., Chairman of the Board and Chief Executive Officer, has announced his intention to retire at the company's Annual Meeting in May 2015.       

TOPICS:

Is McLaren Going to be Pharma’s “Creative Destructionist”?

October 15, 2014 8:51 am | by Girish Malhotra, PE; President, EPCOT International | Blogs | Comments

Since 2011 I have postulated that pharma needs a “creative destructionist” for its manufacturing technology innovations to get out from its archaic “quality by analysis” methods to “quality from the get go methods”. Current practices have cost patients billions in excessive costs. Generally most of the “creative destructionists” are from outside the industry, McLaren could be the one for the pharma and the chemical industry. 

TOPICS:

Hospira Announces Voluntary Nationwide Recall of Certain Lots of Several Lifecare Products

October 15, 2014 8:44 am | News | Comments

Hospira has announced the voluntary recall of certain lots of several products in its LifeCare™ line of flexible intravenous solutions due to the potential for leakage.              

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading